Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results – Conference Call and Webcast Today at 8:30 a.m. ET / 5:30 a.m. PT – PR Newswire TEL AVIV, Israel more...
Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors
CHESTERBROOK, Pa., March 18, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced more...
Celyad Oncology to Announce Full Year 2020 Financial Results and Host Conference Call
MONT-SAINT-GUIBERT, Belgium, March 18, 2021 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for more...
SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 18, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aquestive Therapeutics, Inc. (“Aquestive” or “the more...
ContraFect Corporation Prices Public Offering of Common Stock
YONKERS, N.Y., March 17, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the treatment of life-threatening infectious diseases, today announced the pricing more...
CTI BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results
CTI BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results – Completion of Rolling NDA Submission for Pacritinib for the Treatment of Myelofibrosis Patients with Severe Thrombocytopenia Expected this Month – – Commercialization Activities more...
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has appointed Jenn Adams more...
ContraFect Corporation Announces Proposed Public Offering of Common Stock
YONKERS, N.Y., March 17, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the treatment of life-threatening infectious diseases, today announced that it more...
KalVista Pharmaceuticals, Inc. (KALV) Moves to Buy: Rationale Behind the Upgrade
KalVista Pharmaceuticals, Inc. (KALV) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates — one more...
Adial Founder and Chief Medical Officer Dr. Bankole Johnson Featured Guest on The Black News Channel
Discusses long-term effects of COVID-19 pandemic on mental health and addiction CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on more...